Selected genetic information linked to a documented medication decision.
The clinical question
Allele coverage, structural variants, interactions and interpretation matter. No automatic dosing or blanket coverage.
What to discuss next
Ask about the specific indication, intended scope, responsible clinician or laboratory, and the availability of the pathway. The team must confirm arrangements before care or testing can be planned.
These linked method descriptions explain their specimen, analytical scope and limits. The status of a method and the availability of a service are separate considerations.
pgx / Pharmacogenomics
Actionable pharmacogenomics
Planned
A planned pathway connecting a defined genotype result to an evidence-based clinician review.
Question
Could a documented drug–gene relationship inform a medication decision?
Specimen
Blood, saliva or buccal specimen only as validated by the selected test
Preparation
Provide the relevant medication question; use the exact approved collection kit. No medication should be changed by this preview.
Platform
Targeted genotyping or qualified partner testing; exact coverage pending
Analytical scope
Selected drug-response variants; gene and allele menu pending
Interpretation limits
Genotype is not phenotype. Copy-number, structural-variant, allele and ancestry-related coverage must be disclosed. Drug interactions and history remain important.